A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

CompletedOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

January 12, 2023

Study Completion Date

January 12, 2023

Conditions
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Interventions
DRUG

Perampanel

Perampanel oral tablets or oral suspension.

Trial Locations (36)

Unknown

Sydvestjysk Sygehus Esbjerg, Esbjerg

Hôpital Pontchaillou, Rennes

Hôpital Roger Salengro, Lille

Centre de consultations Saint-Jean Bâtiment A, Cagnes-sur-Mer

Hopitaux de La Timone, Marseille

Hôpital Robert Debré, Paris

Centre hospitalier de Pau, Pau

Centre Hospitalier Universitaire de Toulouse, Toulouse

CHRU Bretonneau, Tours

Eisai Trial Site #2, Berlin

Eisai Trial Site #1, Ulm

AORN A Cardarelli, Naples

Azienda Sanitaria Universitaria Integrata di Udine - PO Universitario Santa Maria della Misericordia, Udine

Fondazione PTV Policlinico Tor Vergata, Rome

ASST Santi Paolo e Carlo - Azienda Universitaria-Polo Universitario San Paolo, Milan

Ospedale di Merano, Merano

Ospedale Santa Maria Della Misericordia Di Perugia, Perugia

Ospedale Policlinico San Martino, Genova

Azienda Ospedaliera Universitaria Federico II, Napoli

Policlinico Universitario Campus Biomedico Di Roma, Roma

Centro Hospitalar E Universitário de Coimbra EPE, Coimbra

Centro Hospitalar Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon

Centro Hospitalar de São João, E.P.E., Porto

Krasnoyarsk State Medical University n.a. V.F. Voyno-Ysenetskiy, Krasnoyarsk

City Clinical Hospital #1 n.a. N.I.Pirogov, Moscow

Moscow State Medical Stomatological University n.a. A.I. Evdokimov, Moscow

Russian National Research Medical University n.a. N.I.Pirogov, Moscow

City Neurology Center Sibneuromed LLC, Novosibirsk

Regional Treatment and Rehabilitation Center, Tyumen

CHUVI - H.U. Alvaro Cunqueiro, Vigo

Hospital Universitari Sagrat Cor Quironsalud, Barcelona

Hospital Universitario Virgen de Las Nieves, Granada

Hospital Regional Universitario de Malaga - Hospital General, Málaga

Hospital Universitario de Donostia, San Sebastián

Hospital Universitario Virgen Macarena, Seville

Hospital Clinico Universitario de Valladolid, Valladolid

All Listed Sponsors
lead

Eisai Limited

INDUSTRY

NCT04252846 - A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy | Biotech Hunter | Biotech Hunter